                         SEQUENCE LISTING

<110>  VANDERBILT UNIVERSITY
 
<120>  STRUCTURAL BASIS FOR ANTIBODY CROSS-NEUTRALIZATION OF RESPIRATORY
        SYNCYTIAL VIRUS AND HUMAN METAPNEUMOVIRUS

<130>  VBLT.P0265WO

<150>  62/451,323
<151>  2017-01-27

<160>  23    

<170>  PatentIn version 3.5

<210>  1
<211>  367
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  1
caggtgcagc tggtggagtc gggggggggc gtggtcaagc cgggggggtc cctgagagtc       60

tcgtgtgttg tctctggatt caccttcagt tcctacagaa tgcactgggt ccgccaggcg      120

ccagggaagg gactggagtg ggtctcctcg attactgcta gtagttctta cataaactac      180

gcagagtcag tgaagggccg attcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgttt attactgtgc gagagacgag      300

aatactggaa tctcccacta ttggttcgac ccctggggcc agggaaccct ggtcaccgtc      360

tcctcag                                                                367


<210>  2
<211>  328
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide


<220>
<221>  misc_feature
<222>  (310)..(310)
<223>  n is a, c, g, or t

<220>
<221>  misc_feature
<222>  (323)..(323)
<223>  n is a, c, g, or t

<220>
<221>  misc_feature
<222>  (326)..(326)
<223>  n is a, c, g, or t

<400>  2
caggctgtgg tgactcagcc gccctcagtg tctggggccc cagggcagag ggtcatcatc       60

tcctgcactg ggagcggttc caacctcggg gcagattatg gtgtacactg gtaccagcaa      120

cttccaggca cagcccccaa acttctcatc tatggtgata ggaatcggcc ctcaggggtc      180

cctgaccgat tctctggctc caagtctggc acctcagcct ccctggccat cactgggctc      240

caggccgagg atgaggctga ttattactgc cagtcctatg acaggagcct gaattgggtg      300

ttggcggagn accaagctga ccntcnta                                         328


<210>  3
<211>  122
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide

<400>  3

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Val Ser Cys Val Val Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Arg Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ser Ile Thr Ala Ser Ser Ser Tyr Ile Asn Tyr Ala Glu Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Glu Asn Thr Gly Ile Ser His Ile Trp Phe Asp Pro Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  4
<211>  109
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide

<400>  4

Gln Ala Val Val Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Ile Ile Ser Cys Thr Gly Ser Gly Ser Asn Leu Gly Ala Asp 
            20                  25                  30          


Tyr Gly Val His Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Gly Asp Arg Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Arg Ser 
                85                  90                  95      


Leu Asn Trp Val Leu Ala Glu Asn Gln Ala Asp Asn Asn 
            100                 105                 


<210>  5
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  5

Gly Phe Thr Phe Ser Ser Tyr Arg 
1               5               


<210>  6
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  6

Ile Thr Ala Ser Ser Ser Tyr Ile 
1               5               


<210>  7
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  7

Ala Arg Asp Glu Asn Thr Gly Ile Ser His Tyr Trp Phe Asp Pro 
1               5                   10                  15  


<210>  8
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  8

Gly Ser Asn Leu Gly Ala Asp Tyr Gly 
1               5                   


<210>  9
<211>  3
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  9

Gly Asp Arg 
1           


<210>  10
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  10

Gln Ser Tyr Asp Arg Ser Leu Asn Trp Val 
1               5                   10  


<210>  11
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  11

Gly Phe Thr Phe Ser Ser Tyr Ser 
1               5               


<210>  12
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  12

Ile Ser Ala Ser Ser Ser Tyr Ser 
1               5               


<210>  13
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  13

Ala Arg Ala Arg Ala Thr Gly Tyr Ser Ser Ile Thr Pro Tyr Phe Asp 
1               5                   10                  15      


Ile 
    


<210>  14
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  14

Ile Ala Ala Ser Ser Ser Tyr Ile 
1               5               


<210>  15
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  15

Ser Ser Ser Asn Ile Gly Ala Gly Tyr Asp 
1               5                   10  


<210>  16
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  16

Tyr Asp Asn Asn Asn 
1               5   


<210>  17
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  17

Gln Ser Tyr Asp Arg Asn Leu Ser Gly Val 
1               5                   10  


<210>  18
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  18

Ser Gly Ser Asn Leu Gly Ala Asp Tyr Gly 
1               5                   10  


<210>  19
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  19

Tyr Gly Asp Arg Asn 
1               5   


<210>  20
<211>  124
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide

<400>  20

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ser Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ser Ile Ser Ala Ser Ser Ser Tyr Ser Asp Tyr Ala Asp Ser Ala 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Thr Ser Leu Phe 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Ile Tyr Phe Cys 
                85                  90                  95      


Ala Arg Ala Arg Ala Thr Gly Tyr Ser Ser Ile Thr Pro Tyr Phe Asp 
            100                 105                 110         


Ile Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 


<210>  21
<211>  110
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide

<400>  21

Gln Ser Val Val Thr Gln Thr Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Tyr Asp Val His Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Asp Asn Asn Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Ala Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Arg Ser 
                85                  90                  95      


Leu Ser Gly Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 110 


<210>  22
<211>  120
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  misc_feature
<222>  (104)..(104)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (108)..(109)
<223>  Xaa can be any naturally occurring amino acid

<400>  22

Gln Ala Val Val Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Ile Ile Ser Cys Thr Gly Ser Gly Ser Asn Leu Gly Ala Asp 
            20                  25                  30          


Tyr Gly Val His Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Gly Asp Arg Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Arg Ser 
                85                  90                  95      


Leu Asn Trp Val Leu Ala Glu Xaa Gln Ala Asp Xaa Xaa Pro Asp Arg 
            100                 105                 110         


Phe Ser Gly Ser Lys Ser Gly Thr 
        115                 120 


<210>  23
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  23

Gly Thr Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly 
1               5                   10                  15      


Gly Gly Ala Ser 
            20  


